Author:
Yang Fei,Kim Mooseob,Gu Lihua,Li Linnan,Yang Li,Wang Zhengtao
Funder
Shanghai Association for Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Analytical Chemistry
Reference22 articles.
1. Pharmacopoeia Commission of People’s Republic of China (2020) Pharmacopoeia of the People’s Republic of China (Part 1). Chinese Medical Science and Technology Press, Beijing, p 212
2. Dan H, Wu J, Peng M, Hu XF, Song CW, Zhou ZW, S, Yu SG, N, Fang NB, (2011) Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet. Saudi Med J 32:701–707 (PMID: 21748207)
3. Liao ML, Shang HH, Li YZ, Li T, Wang M, Zheng YN, Hou WB, Liu CX (2018) An integrated approach to uncover quality marker underlying the effects of Alisma orientale on lipid metabolism, using chemical analysis and network Pharmacology. Phytomedicine 45:93–104. https://doi.org/10.1016/j.phymed.2018.04.006
4. Feng YL, Chen H, Tian T, Chen DQ, Zhao YY, Lin RC (2014) Diuretic and antidiuretic activities of the ethanol and aqueous extracts of Alismatis rhizome. J Ethnopharmacol 154:386–390. https://doi.org/10.1016/j.jep.2014.04.017
5. Miao H, Zhang L, Chen DQ, Chen H, Zhao YY, Ma SC (2017) Urinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia. Biomed Chromatogr 31:3829. https://doi.org/10.1002/bmc.3829